Spectrum Pharmaceuticals Inc.

09/10/2022 | Press release | Distributed by Public on 09/10/2022 05:10

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.